Clinical Trials
22 trialsNCT07590856 2026-05-15
A Preliminary Efficacy of SNA028 in Patients With Advanced Colorectal Cancer Positive for GPA33
SmartNuclide Biopharma
Phase EARLY_PHASE1 Not yet recruiting
NCT07583953 2026-05-13
An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors
Suzhou Abogen Biosciences Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT07542379 2026-04-21
The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT07459283 2026-03-10
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT07412665 2026-02-17
A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.
Beijing Geekgene Technology Co., LTD
Phase EARLY_PHASE1 Not yet recruiting
NCT07266311 2025-12-05
CAR-T for Claudin18.2 Positive Solid Tumors
Chengdu Ucello Biotechnology Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT07243366 2025-11-21
Allogeneic CD19-CAR-NK Cells in Patients With Refractory Myasthenia Gravis
Guangdong ProCapZoom Biosciences Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT07196111 2025-09-29
BAFFR CAR-T Treatment for Relapsed/Refractory B-cell Tumors
Guangzhou Bio-gene Technology Co., Ltd
Phase EARLY_PHASE1 Not yet recruiting
NCT07166263 2025-09-10
Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer
Base Therapeutics (Shanghai) Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT07123662 2025-08-14
γδ T Cell Therapy for Relapse Prevention in High-Risk AML Post-Transplant
Guangzhou Bio-gene Technology Co., Ltd
Phase EARLY_PHASE1 Not yet recruiting
NCT07048353 2025-07-02
CAR-T，MTD
Shandong Qilu Cell Therapy Engineering Technology Co., Ltd
Phase EARLY_PHASE1 Not yet recruiting
NCT07003178 2025-06-04
A Study to Evaluate the Safety and Clinical Efficacy of STR-P004
Starna Therapeutics
Phase EARLY_PHASE1 Not yet recruiting
NCT06976931 2025-05-16
Study on the Safe Dosage and Therapeutic Effect of the Drug YY2201 Tablets on Patients With Advanced Cancer
Jiangsu YaYao Biotechnology Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT06702098 2024-11-22
iNK-r/r AML
Guangzhou Ruixin Biotechnological Co., LTD
Phase EARLY_PHASE1 Not yet recruiting
NCT06646783 2024-10-17
Phase IIT Trial of SNA014
SmartNuclide Biopharma
Phase EARLY_PHASE1 Not yet recruiting
NCT06645301 2024-10-16
BGT007 Treatment for Recurrent/refractory Gastrointestinal Malignancies
BioSyngen Pte Ltd
Phase EARLY_PHASE1 Not yet recruiting
NCT06645314 2024-10-16
Study on the Safety and Efficacy of BST06 Injection in the Treatment of Advanced Hepatocellular Carcinoma
BioSyngen Pte Ltd
Phase EARLY_PHASE1 Not yet recruiting
NCT06613152 2024-09-25
HS-IT201 Injection in the Treatment of Advanced Solid Tumors
Qingdao Sino-Cell Biomedicine Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT06173726 2023-12-18
Investigator-initiated Phase I Exploratory Clinical Study of the Safety, Tolerability, and Efficacy of BST02 Injection in the Treatment of Locally Advanced/Metastatic Liver Cancer
BioSyngen Pte Ltd
Phase EARLY_PHASE1 Not yet recruiting
NCT05979857 2023-11-22
Study of SP-3164 in Relapsed or Refractory Non-Hodgkin's Lymphoma
Salarius Pharmaceuticals, LLC
Phase EARLY_PHASE1 Not yet recruiting
NCT05971576 2023-08-02
A Clinical Study on TILs for the Treatment of Advanced Solid Tumors
Suzhou BlueHorse Therapeutics Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT05971589 2023-08-02
A Clinical Study on LM103 Injection for the Treatment of Advanced Solid Tumors
Suzhou BlueHorse Therapeutics Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting